145 related articles for article (PubMed ID: 8596489)
21. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR
Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057
[TBL] [Abstract][Full Text] [Related]
22. Plasma cholecystokinin response to a liquid fat meal in vagotomized patients.
Hopman WP; Jansen JB; Lamers CB
Ann Surg; 1984 Dec; 200(6):693-7. PubMed ID: 6508396
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a radioimmunoassay for cholecystokinin in human plasma.
Cantor P
Scand J Clin Lab Invest; 1986 May; 46(3):213-21. PubMed ID: 2424076
[TBL] [Abstract][Full Text] [Related]
24. Preferential release of proinsulin relative to insulin in non-insulin-dependent diabetes mellitus.
Deacon CF; Schleser-Mohr S; Ballmann M; Willms B; Conlon JM; Creutzfeldt W
Acta Endocrinol (Copenh); 1988 Dec; 119(4):549-54. PubMed ID: 3059740
[TBL] [Abstract][Full Text] [Related]
25. Elevated plasma levels of pancreastatin (PST) in patients with non-insulin-dependent diabetes mellitus (NIDDM).
Funakoshi A; Tateishi K; Shinozaki H; Matsumoto M; Wakasugi H
Regul Pept; 1990 Sep; 30(2):159-64. PubMed ID: 2274680
[TBL] [Abstract][Full Text] [Related]
26. Radioimmunoassay of cholecystokinin in plasma.
Ohgo S; Takemura J; Oki Y; Nishizono F; Ishikawa E; Yoshimi T; Yamamura T; Seino Y; Matsukura S
Clin Chem; 1988 Aug; 34(8):1579-84. PubMed ID: 3402058
[TBL] [Abstract][Full Text] [Related]
27. High plasma cholecystokinin levels in patients with chronic pancreatitis having abdominal pain.
Funakoshi A; Nakano I; Shinozaki H; Tateishi K; Hamaoka T; Ibayashi H
Am J Gastroenterol; 1986 Dec; 81(12):1174-8. PubMed ID: 3538853
[TBL] [Abstract][Full Text] [Related]
28. Radioimmunoassay of cholecystokinin in human tissue and plasma.
Jansen JB; Lamers CB
Clin Chim Acta; 1983 Jul; 131(3):305-16. PubMed ID: 6883724
[TBL] [Abstract][Full Text] [Related]
29. Persistent decreased plasma cholecystokinin levels in celiac patients under gluten-free diet: respective roles of histological changes and nutrient hydrolysis.
Deprez P; Sempoux C; Van Beers BE; Jouret A; Robert A; Rahier J; Geubel A; Pauwels S; Mainguet P
Regul Pept; 2002 Dec; 110(1):55-63. PubMed ID: 12468110
[TBL] [Abstract][Full Text] [Related]
30. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
Konturek JW
J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
[TBL] [Abstract][Full Text] [Related]
31. Delayed plasma cholecystokinin and gallbladder responses to intestinal fat in patients with Billroth I and II gastrectomy.
Masclee AA; Jansen JB; Driessen WM; Geuskens LM; Lamers CB
Surgery; 1989 Sep; 106(3):502-8. PubMed ID: 2772825
[TBL] [Abstract][Full Text] [Related]
32. Cholecystokinin and gastrin induce cell contraction in pig ileum by interacting with different receptor subtypes.
Botella A; Delvaux M; Berry P; Frexinos J; Bueno L
Gastroenterology; 1992 Mar; 102(3):779-86. PubMed ID: 1537515
[TBL] [Abstract][Full Text] [Related]
33. Effect of Age on Blood Glucose and Plasma Insulin, Glucagon, Ghrelin, CCK, GIP, and GLP-1 Responses to Whey Protein Ingestion.
Giezenaar C; Hutchison AT; Luscombe-Marsh ND; Chapman I; Horowitz M; Soenen S
Nutrients; 2017 Dec; 10(1):. PubMed ID: 29267221
[TBL] [Abstract][Full Text] [Related]
34. Effects of glucose, galactose, and lactose ingestion on the plasma glucose and insulin response in persons with non-insulin-dependent diabetes mellitus.
Ercan N; Nuttall FQ; Gannon MC; Redmon JB; Sheridan KJ
Metabolism; 1993 Dec; 42(12):1560-7. PubMed ID: 8246770
[TBL] [Abstract][Full Text] [Related]
35. Effects of intravenous infusion of amino acids on cholecystokinin release and gallbladder contraction in humans.
Shirohara H; Tabaru A; Otsuki M
J Gastroenterol; 1996 Aug; 31(4):572-7. PubMed ID: 8844480
[TBL] [Abstract][Full Text] [Related]
36. Release of cholecystokinin and gallbladder contraction before and after gastrectomy.
Inoue K; Fuchigami A; Hosotani R; Kogire M; Huang YS; Miyashita T; Suzuki T; Tsuda K; Seino Y; Rayford PL
Ann Surg; 1987 Jan; 205(1):27-32. PubMed ID: 3800460
[TBL] [Abstract][Full Text] [Related]
37. Effect of oral antidiabetic agents on plasma amylin level in patients with non-insulin-dependent diabetes mellitus (type 2).
Zapecka-Dubno B; Czyzyk A; Dworak A; Bak MI
Arzneimittelforschung; 1999 Apr; 49(4):330-4. PubMed ID: 10337452
[TBL] [Abstract][Full Text] [Related]
38. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR
Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
[TBL] [Abstract][Full Text] [Related]
39. Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis.
Mari A
Diabetologia; 1998 Sep; 41(9):1029-39. PubMed ID: 9754821
[TBL] [Abstract][Full Text] [Related]
40. Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility.
McLaughlin J; Grazia Lucà M; Jones MN; D'Amato M; Dockray GJ; Thompson DG
Gastroenterology; 1999 Jan; 116(1):46-53. PubMed ID: 9869601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
